blˈʌndɛlz ɹᵻsˈɜːtʃ ˈɪntɹɛsts lˈaɪ ɪn ᵻlˈuːsᵻdˌeɪɾɪŋ ðɪ ˈɑːɹkɪtˌɛktʃɚ ænd fˈʌŋkʃən ʌv mˈækɹəmˌɑːlɪkjˌuːlz ænd ðɛɹ mˈʌltaɪkəmpˈoʊnənt ɐsˈɛmblɪz jˈuːzɪŋ mˈɛθədz fɹʌm bˌaɪoʊkˈɛmɪstɹi, pɹˈoʊtiːn kɹˌɪstɐlˈɑːɡɹəfi, ænd bˌaɪoʊɪnfɔːɹmˈæɾɪks, wɪððɪ ɑːbdʒˈɛktɪvz ʌv ˌʌndɚstˈændɪŋ bˌaɪəlˈɑːdʒɪkəl fˈʌŋkʃən, ʌv nˈɑːlɪdʒbˈeɪst pɹɪdˈɪkʃən ʌv stɹˈʌktʃɚ, ænd ʌv dɪskˈʌvɚɹɪŋ nˈuː θˌɛɹəpjˈuːɾɪks fɔːɹ kˈænsɚ ænd tˌuːbɚkjʊlˈoʊsɪs.
Blundell's research interests lie in elucidating the architecture and function of macromolecules and their multi-component assemblies using methods from biochemistry, protein crystallography, and bioinformatics, with the objectives of understanding biological function, of knowledge-based prediction of structure, and of discovering new therapeutics for cancer and tuberculosis.